Year archive

Mural Oncology PLC — 2025 filings

All 88 regulatory filings released by Mural Oncology PLC (MURA) in 2025, sourced directly from the official regulator.

88 Filings

2025 Period

2025 filings (88)

Filing	Released	Lang
Major Shareholding Notification 2025 Major Shareholding Notification	2025-12-16	English
15-12G Regulatory Filings	2025-12-15	English
Regulatory Filings 2025 Regulatory Filings	2025-12-09	English
S-8 POS Regulatory Filings	2025-12-05	English
S-8 POS Transaction in Own Shares	2025-12-05	English
S-8 POS Regulatory Filings	2025-12-05	English
POS AM Capital/Financing Update	2025-12-05	English
4 Director's Dealing	2025-12-05	English
4 Director's Dealing	2025-12-05	English
4 Director's Dealing	2025-12-05	English
4 Director's Dealing	2025-12-05	English
4 Director's Dealing	2025-12-05	English
4 Director's Dealing	2025-12-05	English
4 Director's Dealing	2025-12-05	English
4 Director's Dealing	2025-12-05	English
4 Director's Dealing	2025-12-05	English
Delisting Announcement 2025 Delisting Announcement	2025-12-05	English
8-K Delisting Announcement	2025-12-05	English
Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition M&A Activity	2025-12-05	English
Mural Oncology Announces Sanction of the Scheme by the High Court M&A Activity	2025-12-03	English
Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty M&A Activity	2025-11-26	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-11-14	English
4 Director's Dealing	2025-11-11	English
4 Director's Dealing	2025-11-11	English
Regulatory Filings 2025 Regulatory Filings	2025-11-11	English
Regulatory Filings 2025 Regulatory Filings	2025-11-11	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-11-07	English
10-Q Interim / Quarterly Report Q3 2025	2025-11-06	English
8-K Declaration of Voting Results & Voting Rights Announcements	2025-10-24	English
Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty AGM Information	2025-10-24	English
DEFA14A Proxy Solicitation & Information Statement	2025-10-17	English
DEFA14A Proxy Solicitation & Information Statement	2025-10-06	English
Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting Proxy Solicitation & Information Statement	2025-09-24	English
DEFA14A Proxy Solicitation & Information Statement	2025-09-23	English
DEFA14A Proxy Solicitation & Information Statement	2025-09-23	English
DEFA14A Proxy Solicitation & Information Statement	2025-09-23	English
DEFM14A Filing Proxy Solicitation & Information Statement	2025-09-23	English
PREM14A Proxy Solicitation & Information Statement	2025-09-12	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-09-02	English
PRIMARY DOCUMENT Director's Dealing	2025-09-02	English
DEFA14A M&A Activity	2025-08-20	English
8-K M&A Activity	2025-08-20	English
Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share M&A Activity	2025-08-20	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-08-15	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-08-14	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-08-05	English
10-Q Interim / Quarterly Report Q2 2025	2025-08-04	English
8-K Earnings Release	2025-08-04	English
4 Director's Dealing	2025-07-23	English
4 Director's Dealing	2025-07-22	English
Regulatory Filings 2025 Regulatory Filings	2025-07-22	English
Regulatory Filings 2025 Regulatory Filings	2025-07-09	English
4 Director's Dealing	2025-07-09	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-06-26	English
4 Director's Dealing	2025-06-13	English
4 Director's Dealing	2025-06-13	English
4 Director's Dealing	2025-06-13	English
4 Director's Dealing	2025-06-13	English
4 Director's Dealing	2025-06-13	English
8-K Declaration of Voting Results & Voting Rights Announcements	2025-06-12	English
Mural Oncology Announces Number of Relevant Securities in Issue M&A Activity	2025-05-19	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-05-15	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-05-15	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-05-14	English
10-Q Interim / Quarterly Report Q1 2025	2025-05-14	English
FORM 8.1(a) & (b) - Mural Oncology plc M&A Activity	2025-04-30	English
ARS Annual Report	2025-04-28	English
DEFA14A Proxy Solicitation & Information Statement	2025-04-28	English
DEF 14A Proxy Solicitation & Information Statement	2025-04-28	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-04-16	English
8-K Regulatory Filings	2025-04-15	English
8-K Regulatory Filings	2025-03-25	English
8-K Regulatory Filings	2025-03-11	English
424B5 Capital/Financing Update	2025-03-11	English
S-8 Regulatory Filings	2025-03-11	English
10-K Annual Report FY 2024	2025-03-11	English
8-K Regulatory Filings	2025-03-11	English
Regulatory Filings 2025 Regulatory Filings	2025-03-05	English
4 Director's Dealing	2025-03-05	English
4 Director's Dealing	2025-03-05	English
4 Director's Dealing	2025-03-05	English
4 Director's Dealing	2025-03-05	English
Regulatory Filings 2025 Regulatory Filings	2025-03-05	English
4 Director's Dealing	2025-02-25	English
Regulatory Filings 2025 Regulatory Filings	2025-02-24	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-02-14	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-02-14	English
8-K Investor Presentation	2025-01-10	English